Cargando…

Hypoalbuminemia affects the spatio-temporal tissue distribution of ochratoxin A in liver and kidneys: consequences for organ toxicity

Hypoalbuminemia (HA) is frequently observed in systemic inflammatory diseases and in liver disease. However, the influence of HA on the pharmacokinetics and toxicity of compounds with high plasma albumin binding remained insufficiently studied. The ‘lack-of-delivery-concept’ postulates that HA leads...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassan, Reham, Friebel, Adrian, Brackhagen, Lisa, Hobloss, Zaynab, Myllys, Maiju, González, Daniela, Albrecht, Wiebke, Mohammed, Elsayed S. I., Seddek, Abdel-latif, Marchan, Rosemarie, Cadenas, Cristina, Cramer, Benedikt, Humpf, Hans-Ulrich, Hartl, Lukas, Simbrunner, Benedikt, Reiberger, Thomas, Trauner, Michael, Hoehme, Stefan, Degen, Gisela H., Hengstler, Jan G., Ghallab, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525345/
https://www.ncbi.nlm.nih.gov/pubmed/35962801
http://dx.doi.org/10.1007/s00204-022-03361-8
_version_ 1784800685767786496
author Hassan, Reham
Friebel, Adrian
Brackhagen, Lisa
Hobloss, Zaynab
Myllys, Maiju
González, Daniela
Albrecht, Wiebke
Mohammed, Elsayed S. I.
Seddek, Abdel-latif
Marchan, Rosemarie
Cadenas, Cristina
Cramer, Benedikt
Humpf, Hans-Ulrich
Hartl, Lukas
Simbrunner, Benedikt
Reiberger, Thomas
Trauner, Michael
Hoehme, Stefan
Degen, Gisela H.
Hengstler, Jan G.
Ghallab, Ahmed
author_facet Hassan, Reham
Friebel, Adrian
Brackhagen, Lisa
Hobloss, Zaynab
Myllys, Maiju
González, Daniela
Albrecht, Wiebke
Mohammed, Elsayed S. I.
Seddek, Abdel-latif
Marchan, Rosemarie
Cadenas, Cristina
Cramer, Benedikt
Humpf, Hans-Ulrich
Hartl, Lukas
Simbrunner, Benedikt
Reiberger, Thomas
Trauner, Michael
Hoehme, Stefan
Degen, Gisela H.
Hengstler, Jan G.
Ghallab, Ahmed
author_sort Hassan, Reham
collection PubMed
description Hypoalbuminemia (HA) is frequently observed in systemic inflammatory diseases and in liver disease. However, the influence of HA on the pharmacokinetics and toxicity of compounds with high plasma albumin binding remained insufficiently studied. The ‘lack-of-delivery-concept’ postulates that HA leads to less carrier mediated uptake of albumin bound substances into hepatocytes and to less glomerular filtration; in contrast, the ‘concept-of-higher-free-fraction’ argues that increased concentrations of non-albumin bound compounds facilitate hepatocellular uptake and enhance glomerular filtration. To address this question, we performed intravital imaging on livers and kidneys of anesthetized mice to quantify the spatio-temporal tissue distribution of the mycotoxin ochratoxin A (OTA) based on its auto-fluorescence in albumin knockout and wild-type mice. HA strongly enhanced the uptake of OTA from the sinusoidal blood into hepatocytes, followed by faster secretion into bile canaliculi. These toxicokinetic changes were associated with increased hepatotoxicity in heterozygous albumin knockout mice for which serum albumin was reduced to a similar extent as in patients with severe hypoalbuminemia. HA also led to a shorter half-life of OTA in renal capillaries, increased glomerular filtration, and to enhanced uptake of OTA into tubular epithelial cells. In conclusion, the results favor the ‘concept-of-higher-free-fraction’ in HA; accordingly, HA causes an increased tissue uptake of compounds with high albumin binding and increased organ toxicity. It should be studied if this concept can be generalized to all compounds with high plasma albumin binding that are substrates of hepatocyte and renal tubular epithelial cell carriers. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00204-022-03361-8.
format Online
Article
Text
id pubmed-9525345
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-95253452022-10-02 Hypoalbuminemia affects the spatio-temporal tissue distribution of ochratoxin A in liver and kidneys: consequences for organ toxicity Hassan, Reham Friebel, Adrian Brackhagen, Lisa Hobloss, Zaynab Myllys, Maiju González, Daniela Albrecht, Wiebke Mohammed, Elsayed S. I. Seddek, Abdel-latif Marchan, Rosemarie Cadenas, Cristina Cramer, Benedikt Humpf, Hans-Ulrich Hartl, Lukas Simbrunner, Benedikt Reiberger, Thomas Trauner, Michael Hoehme, Stefan Degen, Gisela H. Hengstler, Jan G. Ghallab, Ahmed Arch Toxicol Toxicokinetics and Metabolism Hypoalbuminemia (HA) is frequently observed in systemic inflammatory diseases and in liver disease. However, the influence of HA on the pharmacokinetics and toxicity of compounds with high plasma albumin binding remained insufficiently studied. The ‘lack-of-delivery-concept’ postulates that HA leads to less carrier mediated uptake of albumin bound substances into hepatocytes and to less glomerular filtration; in contrast, the ‘concept-of-higher-free-fraction’ argues that increased concentrations of non-albumin bound compounds facilitate hepatocellular uptake and enhance glomerular filtration. To address this question, we performed intravital imaging on livers and kidneys of anesthetized mice to quantify the spatio-temporal tissue distribution of the mycotoxin ochratoxin A (OTA) based on its auto-fluorescence in albumin knockout and wild-type mice. HA strongly enhanced the uptake of OTA from the sinusoidal blood into hepatocytes, followed by faster secretion into bile canaliculi. These toxicokinetic changes were associated with increased hepatotoxicity in heterozygous albumin knockout mice for which serum albumin was reduced to a similar extent as in patients with severe hypoalbuminemia. HA also led to a shorter half-life of OTA in renal capillaries, increased glomerular filtration, and to enhanced uptake of OTA into tubular epithelial cells. In conclusion, the results favor the ‘concept-of-higher-free-fraction’ in HA; accordingly, HA causes an increased tissue uptake of compounds with high albumin binding and increased organ toxicity. It should be studied if this concept can be generalized to all compounds with high plasma albumin binding that are substrates of hepatocyte and renal tubular epithelial cell carriers. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00204-022-03361-8. Springer Berlin Heidelberg 2022-08-13 2022 /pmc/articles/PMC9525345/ /pubmed/35962801 http://dx.doi.org/10.1007/s00204-022-03361-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Toxicokinetics and Metabolism
Hassan, Reham
Friebel, Adrian
Brackhagen, Lisa
Hobloss, Zaynab
Myllys, Maiju
González, Daniela
Albrecht, Wiebke
Mohammed, Elsayed S. I.
Seddek, Abdel-latif
Marchan, Rosemarie
Cadenas, Cristina
Cramer, Benedikt
Humpf, Hans-Ulrich
Hartl, Lukas
Simbrunner, Benedikt
Reiberger, Thomas
Trauner, Michael
Hoehme, Stefan
Degen, Gisela H.
Hengstler, Jan G.
Ghallab, Ahmed
Hypoalbuminemia affects the spatio-temporal tissue distribution of ochratoxin A in liver and kidneys: consequences for organ toxicity
title Hypoalbuminemia affects the spatio-temporal tissue distribution of ochratoxin A in liver and kidneys: consequences for organ toxicity
title_full Hypoalbuminemia affects the spatio-temporal tissue distribution of ochratoxin A in liver and kidneys: consequences for organ toxicity
title_fullStr Hypoalbuminemia affects the spatio-temporal tissue distribution of ochratoxin A in liver and kidneys: consequences for organ toxicity
title_full_unstemmed Hypoalbuminemia affects the spatio-temporal tissue distribution of ochratoxin A in liver and kidneys: consequences for organ toxicity
title_short Hypoalbuminemia affects the spatio-temporal tissue distribution of ochratoxin A in liver and kidneys: consequences for organ toxicity
title_sort hypoalbuminemia affects the spatio-temporal tissue distribution of ochratoxin a in liver and kidneys: consequences for organ toxicity
topic Toxicokinetics and Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525345/
https://www.ncbi.nlm.nih.gov/pubmed/35962801
http://dx.doi.org/10.1007/s00204-022-03361-8
work_keys_str_mv AT hassanreham hypoalbuminemiaaffectsthespatiotemporaltissuedistributionofochratoxinainliverandkidneysconsequencesfororgantoxicity
AT friebeladrian hypoalbuminemiaaffectsthespatiotemporaltissuedistributionofochratoxinainliverandkidneysconsequencesfororgantoxicity
AT brackhagenlisa hypoalbuminemiaaffectsthespatiotemporaltissuedistributionofochratoxinainliverandkidneysconsequencesfororgantoxicity
AT hoblosszaynab hypoalbuminemiaaffectsthespatiotemporaltissuedistributionofochratoxinainliverandkidneysconsequencesfororgantoxicity
AT myllysmaiju hypoalbuminemiaaffectsthespatiotemporaltissuedistributionofochratoxinainliverandkidneysconsequencesfororgantoxicity
AT gonzalezdaniela hypoalbuminemiaaffectsthespatiotemporaltissuedistributionofochratoxinainliverandkidneysconsequencesfororgantoxicity
AT albrechtwiebke hypoalbuminemiaaffectsthespatiotemporaltissuedistributionofochratoxinainliverandkidneysconsequencesfororgantoxicity
AT mohammedelsayedsi hypoalbuminemiaaffectsthespatiotemporaltissuedistributionofochratoxinainliverandkidneysconsequencesfororgantoxicity
AT seddekabdellatif hypoalbuminemiaaffectsthespatiotemporaltissuedistributionofochratoxinainliverandkidneysconsequencesfororgantoxicity
AT marchanrosemarie hypoalbuminemiaaffectsthespatiotemporaltissuedistributionofochratoxinainliverandkidneysconsequencesfororgantoxicity
AT cadenascristina hypoalbuminemiaaffectsthespatiotemporaltissuedistributionofochratoxinainliverandkidneysconsequencesfororgantoxicity
AT cramerbenedikt hypoalbuminemiaaffectsthespatiotemporaltissuedistributionofochratoxinainliverandkidneysconsequencesfororgantoxicity
AT humpfhansulrich hypoalbuminemiaaffectsthespatiotemporaltissuedistributionofochratoxinainliverandkidneysconsequencesfororgantoxicity
AT hartllukas hypoalbuminemiaaffectsthespatiotemporaltissuedistributionofochratoxinainliverandkidneysconsequencesfororgantoxicity
AT simbrunnerbenedikt hypoalbuminemiaaffectsthespatiotemporaltissuedistributionofochratoxinainliverandkidneysconsequencesfororgantoxicity
AT reibergerthomas hypoalbuminemiaaffectsthespatiotemporaltissuedistributionofochratoxinainliverandkidneysconsequencesfororgantoxicity
AT traunermichael hypoalbuminemiaaffectsthespatiotemporaltissuedistributionofochratoxinainliverandkidneysconsequencesfororgantoxicity
AT hoehmestefan hypoalbuminemiaaffectsthespatiotemporaltissuedistributionofochratoxinainliverandkidneysconsequencesfororgantoxicity
AT degengiselah hypoalbuminemiaaffectsthespatiotemporaltissuedistributionofochratoxinainliverandkidneysconsequencesfororgantoxicity
AT hengstlerjang hypoalbuminemiaaffectsthespatiotemporaltissuedistributionofochratoxinainliverandkidneysconsequencesfororgantoxicity
AT ghallabahmed hypoalbuminemiaaffectsthespatiotemporaltissuedistributionofochratoxinainliverandkidneysconsequencesfororgantoxicity